Company announcements · 13.11.2026 г.1 min read

Leqembi® Pen subcutaneous treatment launched in Japan

Локален автоматски превод · Оригинален јазик на изворот

Illustration generated by Business News; it is not a source photograph.

Резиме

STOCKHOLM, Nov. 13, 2026 — BioArctic AB's (publ) (NASDAQ Stockholm: BIOA B) partner Eisai today announced that Leqembi Pen, the subcutaneous formulation of lecanemab, has been launched in Japan for the…

Оригинален јазик на изворот: PR Newswire UK — News ReleasesПрочитајте го оригиналот →